Cantor Remains Neutral On Aleafia Health, Lowers Price Target On Sectoral Derating, Sees Value
Canadian cannabis company Aleafia Health (OTCQF: ALEAF) recently disclosed its first-quarter financial results with net revenue of CA$7.06 milli
EXCLUSIVE: Hexo CEO Urges Consumers To Demand Carbon Neutrality From Companies As Cannabis Giant Commits To This Initiative
“Be the change that you wish to see in the world," Mahatma Gandhi said.
Psyched: Atai’s $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers
Atai Launches $214 Million Nasdaq IPO Offering
Psychedelics biotech platform Atai life Sciences has announced an initial public offering of approximately 14 million of its common shares, ahead of the company’s expected Nasdaq listing.
Cannabis Stock Gainers And Losers From June 11, 2021
GAINERS:
CURE Pharmaceutical Hldg (OTC: CURR) shares closed up 12.33% at $0.82
The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More
As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date.
This week, however, stocks posted mixed performances.
Cannabis Co. Flora Growth Completed $2.4M Investment In Hoshi International
Flora Growth Corp. (NASDAQ: FLGC) made a strategic investment of 2 million Euros ($2.42 million) in Hoshicap Portugal Unipessoal Lda, a subsidiary of Hoshi International. The investment will solidify Flora's position as a preferred strategic supplier to Hoshi's EU processing facilitie
Columbia Care Launches Tool To Discover Cannabis Based On Mood, Activity, More
Columbia Care Inc (OTC: CCHWF) has launched Forage, a cannabis discovery tool designed to make product recommendations curated based on your mood, activity and consumption preference.
Federally Compliant Medical Cannabis In The US? One Company Is Doing It
CURE Pharmaceutical (OTC: CURR) has signed an agreement with Biopharmaceutical Research Company (BRC) to produce federally compliant medical cannabis, CBD and THC products.
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offering.
Columbia Care Strengthens Position In Mid-Atlantic Via $240M Acquisition Of Green Lead Medical
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) revealed Friday it has finalized its purchase of privately-held cannabis company Green Leaf Medical, LLC, for $240 million in stock and cash.